Successful long-term treatment of post-transplant erythrocytosis with losartan.
Midtvedt
K
K
Section of Nephrology, Medical Department B, National Hospital, Oslo, Norway.
Stokke
E S
ES
Hartmann
A
A
D000328:Adult; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D004921:Erythropoietin / Q000097:blood; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D019808:Losartan; D011086:Polycythemia / Q000188:drug therapy* / Q000209:etiology*; D013777:Tetrazoles / Q000627:therapeutic use*; D013997:Time Factors
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D006454:Hemoglobins; D007093:Imidazoles; D013777:Tetrazoles; D004921:Erythropoietin; D019808:Losartan